Practitioners are confronted with a myriad of cutaneous diseases affecting skin of color. Skin of color, which encompasses the pigmented skin of those of African American, Asian and Hispanic descent is susceptible to several unique and cosmetically disfiguring problems. Acne vulgaris, pseudofolliculitis barbae, postinflammatory hyperpigmentation and photoaging are diseases which commonly necessitate visits to the dermatologist and are of major cosmetic concern for those with skin of color. Effective treatments are needed to quickly resolve the inflammatory lesions of acne and pseudofolliculitis. The number of agents available for the treatment of postinflammatory hyperpigmentation is limited, and some agents are minimally effective. In addition to more effective therapeutic agents, development of enhanced camouflaging techniques are also necessary. Finally, sunscreens which provide more complete protection for skin of color are needed to address the issue of both photoaging and hyperpigmentation. We look to the cosmetic industry to develop new products and to improve currently existing products to address the cosmetic concerns of skin of color.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.